Product was Co-Diagnostics’s largest product and service line in fiscal 2025, bringing in $418.21K of $622.49K (67%).
| Product and Service | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Product Revenue | $34.22M | $991.47K | — | — |
| Grant Revenue | — | $5.82M | — | — |
| Grant | — | — | $3.15M | $204.28K |
| Product | — | — | $770.05K | $418.21K |
| Total | $34.22M | $6.81M | $3.92M | $622.49K |
Co-Diagnostics brought in $622.49K from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 84.1% from $3.92M in fiscal 2024. Product was the largest at $418.21K (67.2%), ahead of Grant at $204.28K (32.8%).
Compared with fiscal 2024, Product fell 45.7% to $418.21K and Grant fell 93.5% to $204.28K.
Co-Diagnostics began breaking out Grant in fiscal 2024 and Product in fiscal 2024. Co-Diagnostics stopped reporting Grant Revenue ($5.82M in fiscal 2023) and Product Revenue ($991.47K in fiscal 2023) as separate lines.
United States was Co-Diagnostics’s largest region in fiscal 2025, bringing in $581.55K of $622.49K (93%).
| Geography | FY 2024 | FY 2025 |
|---|---|---|
| United States | $3.52M | $581.55K |
| Non-Us | $391.84K | $40.94K |
| Total | $3.92M | $622.49K |
Co-Diagnostics brought in $622.49K from its two regions in fiscal 2025, the year ended December 31, 2025. That was down 84.1% from $3.92M in fiscal 2024. United States was the largest at $581.55K (93.4%), ahead of Non-Us at $40.94K (6.6%).
Compared with fiscal 2024, United States fell 83.5% to $581.55K and Non-Us fell 89.6% to $40.94K.
Co-Diagnostics (CODX) reports its revenue by product and service and by geography. In fiscal 2025, Product was its largest product and service line, bringing in $418.21K (67.2% of the total), followed by Grant at $204.28K (32.8%).
Product was Co-Diagnostics' largest product and service line in fiscal 2025, bringing in $418.21K, or 67.2% of the $622.49K total across its two product and service lines.
United States was Co-Diagnostics' largest region in fiscal 2025, bringing in $581.55K, or 93.4% of the $622.49K total across its two regions.
Every figure comes from Co-Diagnostics' annual financial filings, as reported. Each line keeps the name Co-Diagnostics gives it, and years follow its fiscal calendar.
Co-Diagnostics' revenue by product and service goes back to fiscal 2022, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.